Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Countries

Islam Eljilany, Faris El-Dahiyat, Louise Elizabeth Curley, Zaheer-Ud-Din Babar

Research output: Contribution to journalArticle

Abstract

Background: The importance of pharmacoeconomics and health economics has been augmented. It has the potential to provide evidence to aid in optimal decision-making in the funding of cost-effective medicines and services in Gulf Cooperation Council countries (G.C.C). Objective: To evaluate the quality and quantity of health economic researches published until the end of 2017 in G.C.C. and to identify the factors that affect the quality of studies. Method: Studies were included according to predefined inclusion and exclusion criteria. The quantity was recorded, and the quality was assessed using the Quality of Health Economic Studies (QHES) instrument. Results: Forty-nine studies were included. The mean (SD) quality score of all studies was 57.83 (25.05), and a high number of reviewed studies (47%) were evaluated as either poor or extremely poor quality. The factors that affect the quality of studies with statistical significance were, the type and method of economic evaluation, the economic outcome was the objective of the research, author`s background, the perspective of the study, health intervention and source of funding. Conclusion: The use of economic evaluation studies in G.C.C was limited. Different factors that affect the quality of articles such as performing a full economic evaluation and choosing societal perspective were identified. Strategies to improve the quality of future studies were recommended.

Original languageEnglish
Pages (from-to)403-414
Number of pages12
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume18
Issue number4
Early online date30 May 2018
DOIs
Publication statusPublished - 4 Jul 2018

Fingerprint

Pharmaceutical Economics
Economics
Cost-Benefit Analysis
Health
Research
Decision Making
Costs and Cost Analysis

Cite this

@article{f647a9219e084a02a89c8f998427e90b,
title = "Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Countries",
abstract = "Background: The importance of pharmacoeconomics and health economics has been augmented. It has the potential to provide evidence to aid in optimal decision-making in the funding of cost-effective medicines and services in Gulf Cooperation Council countries (G.C.C). Objective: To evaluate the quality and quantity of health economic researches published until the end of 2017 in G.C.C. and to identify the factors that affect the quality of studies. Method: Studies were included according to predefined inclusion and exclusion criteria. The quantity was recorded, and the quality was assessed using the Quality of Health Economic Studies (QHES) instrument. Results: Forty-nine studies were included. The mean (SD) quality score of all studies was 57.83 (25.05), and a high number of reviewed studies (47{\%}) were evaluated as either poor or extremely poor quality. The factors that affect the quality of studies with statistical significance were, the type and method of economic evaluation, the economic outcome was the objective of the research, author`s background, the perspective of the study, health intervention and source of funding. Conclusion: The use of economic evaluation studies in G.C.C was limited. Different factors that affect the quality of articles such as performing a full economic evaluation and choosing societal perspective were identified. Strategies to improve the quality of future studies were recommended.",
keywords = "Gulf Cooperation Council, health economics, Pharmacoeconomics, QHES, quality, quality of literature",
author = "Islam Eljilany and Faris El-Dahiyat and Curley, {Louise Elizabeth} and Zaheer-Ud-Din Babar",
note = "This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Pharmacoeconomics and Outcomes Research on 30 May 2018, available online: http://www.tandfonline.com/10.1080/14737167.2018.1479254.",
year = "2018",
month = "7",
day = "4",
doi = "10.1080/14737167.2018.1479254",
language = "English",
volume = "18",
pages = "403--414",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "4",

}

Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Countries. / Eljilany, Islam; El-Dahiyat, Faris; Curley, Louise Elizabeth; Babar, Zaheer-Ud-Din.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 18, No. 4, 04.07.2018, p. 403-414.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Countries

AU - Eljilany, Islam

AU - El-Dahiyat, Faris

AU - Curley, Louise Elizabeth

AU - Babar, Zaheer-Ud-Din

N1 - This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Pharmacoeconomics and Outcomes Research on 30 May 2018, available online: http://www.tandfonline.com/10.1080/14737167.2018.1479254.

PY - 2018/7/4

Y1 - 2018/7/4

N2 - Background: The importance of pharmacoeconomics and health economics has been augmented. It has the potential to provide evidence to aid in optimal decision-making in the funding of cost-effective medicines and services in Gulf Cooperation Council countries (G.C.C). Objective: To evaluate the quality and quantity of health economic researches published until the end of 2017 in G.C.C. and to identify the factors that affect the quality of studies. Method: Studies were included according to predefined inclusion and exclusion criteria. The quantity was recorded, and the quality was assessed using the Quality of Health Economic Studies (QHES) instrument. Results: Forty-nine studies were included. The mean (SD) quality score of all studies was 57.83 (25.05), and a high number of reviewed studies (47%) were evaluated as either poor or extremely poor quality. The factors that affect the quality of studies with statistical significance were, the type and method of economic evaluation, the economic outcome was the objective of the research, author`s background, the perspective of the study, health intervention and source of funding. Conclusion: The use of economic evaluation studies in G.C.C was limited. Different factors that affect the quality of articles such as performing a full economic evaluation and choosing societal perspective were identified. Strategies to improve the quality of future studies were recommended.

AB - Background: The importance of pharmacoeconomics and health economics has been augmented. It has the potential to provide evidence to aid in optimal decision-making in the funding of cost-effective medicines and services in Gulf Cooperation Council countries (G.C.C). Objective: To evaluate the quality and quantity of health economic researches published until the end of 2017 in G.C.C. and to identify the factors that affect the quality of studies. Method: Studies were included according to predefined inclusion and exclusion criteria. The quantity was recorded, and the quality was assessed using the Quality of Health Economic Studies (QHES) instrument. Results: Forty-nine studies were included. The mean (SD) quality score of all studies was 57.83 (25.05), and a high number of reviewed studies (47%) were evaluated as either poor or extremely poor quality. The factors that affect the quality of studies with statistical significance were, the type and method of economic evaluation, the economic outcome was the objective of the research, author`s background, the perspective of the study, health intervention and source of funding. Conclusion: The use of economic evaluation studies in G.C.C was limited. Different factors that affect the quality of articles such as performing a full economic evaluation and choosing societal perspective were identified. Strategies to improve the quality of future studies were recommended.

KW - Gulf Cooperation Council

KW - health economics

KW - Pharmacoeconomics

KW - QHES

KW - quality

KW - quality of literature

UR - http://www.scopus.com/inward/record.url?scp=85047916197&partnerID=8YFLogxK

U2 - 10.1080/14737167.2018.1479254

DO - 10.1080/14737167.2018.1479254

M3 - Article

VL - 18

SP - 403

EP - 414

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 4

ER -